| Weight Management |
1 |
1 |
| Type 2 Diabetes Mellitus |
0 |
0.9 |
| Weight Loss |
0 |
0.77 |
| Obesity |
0 |
0.56 |
| Revenue and Practice Management |
0 |
0.37 |
| GLP-1 Receptor Agonist |
0 |
0.33 |
| Drug Costs |
0 |
0.29 |
| Electronic Health Record (EHR) |
0 |
0.28 |
| Medical Life |
0 |
0.27 |
| Patient Safety |
0 |
0.25 |
| Adverse Effects |
0 |
0.19 |
| Insurance |
0 |
0.19 |
| Receptors |
0 |
0.19 |
| Renal Disease |
0 |
0.14 |
| Abdominal Infection |
0 |
0.1 |
| Cardiometabolic Risk Factors |
0 |
0.1 |
| Clinical Research |
0 |
0.1 |
| Connecticut |
0 |
0.1 |
| Electronic Medical Record |
0 |
0.1 |
| Fellowship |
0 |
0.1 |
| Gastroparesis |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Hand |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Hyperlipidemia |
0 |
0.1 |
| Hypertension |
0 |
0.1 |
| Internship |
0 |
0.1 |
| Jobs |
0 |
0.1 |
| Kidney |
0 |
0.1 |
| Limb |
0 |
0.1 |
| Lipids Management |
0 |
0.1 |
| Match |
0 |
0.1 |
| Pancreatitis |
0 |
0.1 |
| Residency |
0 |
0.1 |
| Risk Management |
0 |
0.1 |
| Salary and Compensation |
0 |
0.1 |
| Translational Research |
0 |
0.1 |